Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick von Grabowiecki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|June 27, 2022
Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in CancerYannick von Grabowiecki, Vinaya Phatak, Lydia Aschauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2014
Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophyYannick von Grabowiecki, Cynthia Licona, Lavinia Palamiuc, et al.
The Journal of Biological Chemistry|October 18, 2011
Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neuronsSamir Benosman, Xiangjun Meng, Yannick Von Grabowiecki, et al.
Clinical Pharmacology and Therapeutics|May 13, 2024
Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof-of-Concept Application of Liquid Biopsy in Renal ImpairmentAmin Rostami-Hodjegan, Zubida M Al-Majdoub, Yannick von Grabowiecki, et al.
Elife|February 27, 2016
Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63Yannick von Grabowiecki, Paula Abreu, Orphee Blanchard, et al.
Cell Death & Disease|February 25, 2021
Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membraneVinaya Phatak, Yannick von Grabowiecki, Justyna Janus, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|June 27, 2022
Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in CancerYannick von Grabowiecki, Vinaya Phatak, Lydia Aschauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2014
Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophyYannick von Grabowiecki, Cynthia Licona, Lavinia Palamiuc, et al.
The Journal of Biological Chemistry|October 18, 2011
Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neuronsSamir Benosman, Xiangjun Meng, Yannick Von Grabowiecki, et al.
Clinical Pharmacology and Therapeutics|May 13, 2024
Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof-of-Concept Application of Liquid Biopsy in Renal ImpairmentAmin Rostami-Hodjegan, Zubida M Al-Majdoub, Yannick von Grabowiecki, et al.
Elife|February 27, 2016
Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63Yannick von Grabowiecki, Paula Abreu, Orphee Blanchard, et al.
Cell Death & Disease|February 25, 2021
Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membraneVinaya Phatak, Yannick von Grabowiecki, Justyna Janus, et al.
Pageof 1